WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

  • WJPPS: NOVEMBER ISSUE PUBLISHED
  • NOVEMBER 2024 Issue has been successfully launched on NOVEMBER 2024.

Abstract

PIPERACILLIN/TAZOBACTAM INDUCED CHILLS AND BREATH-LESSNESS IN A PATIENT WITH DIABETES MELLITUS: A RARE CASE REPORT

Kush Nimron, Johncy Nathasha, Jithin*, Mariya Shaju, Parvathi K. and Atrisha Mariyam Vincent

ABSTRACT

Objective: To report a rare case of a diabetes mellitus patient who de-veloped chills and breathlessness secondary to Piperacillin Tazobac-tum use. Case Summary: In our case report, we describe an unusual case of an immediate reaction to Piperacillin /Tazobactam. A 77-year-old male patient was admitted to the hospital with chief complaints of pain, swelling, and a non-healing ulcer on the left foot. The patient was ini-tially managed with an injection of Pantoprazole and injection of Para-cetamol with subsequent administration of Piperacillin Tazobactum (4.5 gm) antibiotic to treat the underlying infection. The patient devel-oped chills and breathlessness after receiving the first dose of Pipera-cillin Tazobactum, the antibiotic was stopped and supportive treatment with antihistamine and corticosteroid was provided to treat adverse reactions. The symptoms were resolved and the patient condition improved within one day of discontinuation of the suspected drug. The suspected drug reaction with Piperacillin Tazobactum was found to have a “probable” causal relationship through the Naranjo causality assessment and WHO-UMC scale. The severity of the ADR falls under level 3 as a “moderate” severe reaction as per Adapted Hartwig‟s assessment. The report suggests close monitoring of Piperacillin-Tazobactam usage among the patient population. Practice Implications: Through the obser-vation of this event we could figure out the association between Piperacillin Tazobactum and chills and breathlessness. Prompt withdrawal of the offending agent and the initiation of the therapy with injection pheniramine and injection hydrocortisone was found to be effective.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More